Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2016-02-03
2020-01-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary outcome: Rate of hospital readmission for heart failure Secondary outcomes: Quality of life, Perceived effect of the intervention on heart-failure related care
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial of Telemonitoring in Adults With Heart Failure
NCT01393314
Telemonitoring in Patients With Heart Failure
NCT00502255
Better Effectiveness After Transition - Heart Failure
NCT01360203
CHF Home Telemonitoring: A Home Telemonitoring Service for Chronic Heart Failure Patients on Trial
NCT02489370
LINK-HF2 - Remote Monitoring Analytics in Heart Failure
NCT04502563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Total participation in this study will last 45 days after patient is discharged from the hospital.
Regardless of the assigned group, participant will be asked to complete two questionnaires after 45 days. A member of the research team will contact participant by phone to complete these questionnaires. One of these questionnaires will investigate their quality of life; the other will assess how participant feel the care they have received has affected their health. Patients assigned to the iGetBetter group will also complete a third survey about their satisfaction with the program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemonitoring
Subjects were assigned to web based telemonitoring system.
web based telemonitoring system
Subjects in the telemonitoring group were given an iPad with installed iHealth application, a scale, and an electronic blood pressure monitor (a mobile web-based telemonitoring system). These devices were interconnected via Bluetooth. The iPad had permanent internet connection. Patients were taught to use the equipment to check and record their weight, blood pressure, and heart rate every morning, for 45 days after the hospital discharge. Data was automatically uploaded via iHealth application in a secure database.
Control
Subjects were assigned to conventional monitoring.
Conventional
Subjects in the control group received the standard patient teaching, including an instruction to self-monitor their weight.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
web based telemonitoring system
Subjects in the telemonitoring group were given an iPad with installed iHealth application, a scale, and an electronic blood pressure monitor (a mobile web-based telemonitoring system). These devices were interconnected via Bluetooth. The iPad had permanent internet connection. Patients were taught to use the equipment to check and record their weight, blood pressure, and heart rate every morning, for 45 days after the hospital discharge. Data was automatically uploaded via iHealth application in a secure database.
Conventional
Subjects in the control group received the standard patient teaching, including an instruction to self-monitor their weight.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to Danbury Hospital with heart failure
* NYHA functional class II-IV
Exclusion Criteria
* ESRD on HD
* Severe COPD (O2/steroid dependent?)
* Pregnancy
* Hospice patients/bed bound patients
* Severe valvular disease, or recent valvular intervention (within 1 year) or planned valvular intervention.
* Expected to be transferred to another acute care hospital
* Solid organ transplant recipient or listed for transplant, recipient of left ventricular assist device or planned to receive one
* Homeless participants
* Active psychiatric disorders, addiction
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danbury Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ira Galin
Associate Director of the vascular Medicine Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ira Galin, MD
Role: PRINCIPAL_INVESTIGATOR
Danbury Hospital, Nuvance Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danbury Hospital
Danbury, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-608
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.